Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Non-Current Debt (2019 - 2022)

Korro Bio (KRRO) has disclosed Non-Current Debt for 3 consecutive years, with $4.2 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Non-Current Debt fell 70.59% year-over-year to $4.2 million, compared with a TTM value of $4.2 million through Dec 2022, down 70.59%, and an annual FY2022 reading of $4.2 million, down 70.59% over the prior year.
  • Non-Current Debt was $4.2 million for Q4 2022 at Korro Bio, down from $6.7 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $15.0 million in Q4 2020 and bottomed at $4.2 million in Q4 2022.
  • Average Non-Current Debt over 3 years is $11.8 million, with a median of $14.2 million recorded in 2021.
  • The sharpest move saw Non-Current Debt decreased 5.55% in 2021, then tumbled 70.59% in 2022.
  • Year by year, Non-Current Debt stood at $15.0 million in 2020, then fell by 5.55% to $14.2 million in 2021, then plummeted by 70.59% to $4.2 million in 2022.
  • Business Quant data shows Non-Current Debt for KRRO at $4.2 million in Q4 2022, $6.7 million in Q3 2022, and $9.2 million in Q2 2022.